Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Bài báo
|
Ligelizumab for chronic spontaneous urticaria2019 Massachusetts Medical Society. All rights reserved info:eu-repo/semantics/openAccess ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1900408Tài liệu số/Tài liệu điện tử |
|
2 |
Material Type: Bài báo
|
Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma2019 Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher. https://creativecommons.org/licenses/by-nc/4.0 info:eu-repo/semantics/openAccess ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2017.180505Tài liệu số/Tài liệu điện tử |
|
3 |
Material Type: Bài báo
|
Change over time in the rates of adverse events in patients receiving systemic therapy for psoriasis: A cohort studyElsevier http://dx.doi.org/10.1016/j.jaad.2017.10.051 info:eu-repo/semantics/openAccess ;ISSN: 0190-9622 ;EISSN: 1097-6787 ;DOI: 10.1016/j.jaad.2017.10.051Tài liệu số/Tài liệu điện tử |
|
4 |
Material Type: Bài báo
|
Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticariaThis is the pre-peer reviewed version of the following article: urto-Barredo L, Spertino J, Figueras-Nart I, Expósito-Serrano V, Guilabert A, Melé-Ninot G. et al. Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticarial. Br J Dermatol. 2018 Jul;179(1):210-212., which has been published in final form at http://dx.doi.org/10.1111/bjd.16379. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. info:eu-repo/semantics/openAccess ;ISSN: 0007-0963 ;EISSN: 1365-2133 ;DOI: 10.1111/bjd.16379Tài liệu số/Tài liệu điện tử |
|
5 |
Material Type: Bài báo
|
Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumabThis is the pre-peer reviewed version of the following article: Weller K, Ohanyan T, Hawro T, Ellrich A, Sussman G, Koplowitz J. et al. Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab. Allergy. 2018 Dec;73(12):2406-2408, which has been published in final form at http://dx.doi.org/10.1111/all.13586. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. info:eu-repo/semantics/openAccess ;ISSN: 0105-4538 ;EISSN: 1398-9995 ;DOI: 10.1111/all.13586Tài liệu số/Tài liệu điện tử |
|
6 |
Material Type: Bài báo
|
Wells syndrome and chronic spontaneous urticaria: report of four cases successfully treated with omalizumabThis is the peer reviewed version of the following article: Ogueta I, Spertino J, Deza G, Alcantara Luna S, Zaragoza Ninet V, Pujol R. et al. Wells syndrome and chronic spontaneous urticaria: report of four cases successfully treated with omalizumab. J Eur Acad Dermatol Venereol. 2019 Oct; 33(10):e388-91, which has been published in final form at http://dx.doi.org/10.1111/jdv.15683. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. info:eu-repo/semantics/openAccess ;ISSN: 0926-9959 ;EISSN: 1468-3083 ;DOI: 10.1111/jdv.15683Tài liệu số/Tài liệu điện tử |
|
7 |
Material Type: Bài báo
|
Response to letter to the editor from Viola et al: "calcifediol treatment and COVID-19-related outcomes"Oxford University Press. This is a pre-copyedited, author-produced version of an article accepted for publication in The Journal of clinical endocrinology and metabolism following peer review. The version of record Nogues X, Quesada-Gomez JM, Garcia-Giralt N. Response to letter to the editor from Viola et al: "calcifediol treatment and COVID-19-related outcomes". J Clin Endocrinol Metab. 2021 Nov 19; 106(12): e5281-2, is available online at: https://academic.oup.com/jcem/article/106/12/e5281/6333153?login=true. info:eu-repo/semantics/openAccess ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/clinem/dgab566Tài liệu số/Tài liệu điện tử |
|
8 |
Material Type: Bài báo
|
Cathepsin D as biomarker in cerebrospinal fluid of nusinersen-treated patients with spinal muscular atrophy2022 David C. Schorling et al. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made https://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess ;ISSN: 1351-5101 ;EISSN: 1468-1331 ;DOI: 10.1111/ene.15331Tài liệu số/Tài liệu điện tử |
|
9 |
Material Type: Bài báo
|
Translational reprogramming in tumour cells can generate oncoselectivity in viral therapiesCopyright © 2017, The Author(s). This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/ncomms14833Tài liệu số/Tài liệu điện tử |
|
10 |
Material Type: Bài báo
|
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: a Biobadaderm cohort analysisElsevier http://dx.doi.org/10.1016/j.jaad.2020.10.046 info:eu-repo/semantics/openAccess ;ISSN: 0190-9622 ;EISSN: 1097-6787 ;DOI: 10.1016/j.jaad.2020.10.046Tài liệu số/Tài liệu điện tử |